Coherus, Amgen End Patent War Over Humira Biosimilar
By Hannah Albarazi ( November 27, 2019, 4:01 PM EST) -- Coherus BioSciences Inc. and biopharmaceutical giant Amgen Inc. agreed to end a patent infringement lawsuit in Delaware federal court Tuesday over Amgen's biosimilar formulation of the popular immunosuppressant drug Humira....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.